OTCMKTS:IRSB Iris BioTechnologies (IRSB) Stock Price, News & Analysis → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free IRSB Stock Alerts $0.04 0.00 (0.00%) (As of 08/20/2019) Add Compare Share Share Today's Range$0.04▼$0.0450-Day Range$0.04▼$0.0452-Week Range$0.04▼$0.41VolumeN/AAverage Volume8,024 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Iris BioTechnologies alerts: Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Iris BioTechnologies Stock (OTCMKTS:IRSB)Iris BioTechnologies, Inc., a life science company, develops solutions for the detection and monitoring of monogenic and complex genomic diseases. It is developing nano-biochip technology platform used for the diagnosis and treatment of patients with breast cancer, neurological disorders, heart diseases, diabetes, and other gene-related metabolic problems. The company also develops BioWindows, an artificial intelligence system, which provides data and analysis for clinical applications, drug development, and stem cell research. Iris BioTechnologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.Read More IRSB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IRSB Stock News HeadlinesMarch 29, 2024 | latimes.comThe IRS has unclaimed tax refunds that are about to expire. Is one of them yours?March 27, 2024 | money.usnews.comWhat Really Happens During an IRS Tax AuditApril 30, 2024 | The Bull Report (Ad)Healthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.March 2, 2024 | msn.comIris Apfel Dies: Fashion Icon Captured In Documentary Film Was 102February 1, 2024 | investopedia.comHow to Negotiate Back Tax Payments With the IRSDecember 27, 2023 | investopedia.comIRS Form 8880: Who Qualifies for the Retirement Saver's CreditDecember 22, 2023 | cnbc.comIRS to waive $1 billion in penalties. Here's who qualifies and how much taxpayers may getDecember 2, 2023 | investopedia.comThe Truth About IRS Tax Settlement FirmsApril 30, 2024 | The Bull Report (Ad)Healthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.November 13, 2023 | nypost.comIRS sets new tax brackets, standard deduction for 2024 — How much will you pay?November 13, 2023 | usatoday.comNew IRS tax brackets and standard deductions for 2024: See how much they were raisedNovember 10, 2023 | foxnews.comIRS policy allowing surprise visits on taxpayers limited after Judiciary Republicans' probing, report saysNovember 9, 2023 | forbes.comERC — IRS Withdrawal Process — What Should Business Owners Do?October 13, 2023 | usatoday.comDid you profit big from re-selling Taylor Swift or Beyoncé tickets? The IRS is asking.October 2, 2023 | foxnews.comIRS agent said CNN has Hunter Biden email where Hunter claimed legal 'stuff' would go away under Biden adminSeptember 25, 2023 | nypost.comMerrick Garland’s Hunter lies blown up YET AGAIN by IRS whistleblowersSeptember 23, 2023 | foxnews.comHunter Biden lawsuit against IRS a 'frivolous smear' to discourage more whistleblowers, attorney saysSeptember 11, 2023 | foxnews.comIRS whistleblower's attorney questions contact with Garland subordinate: 'Sounded like intel-gathering'August 21, 2023 | foxnews.comIRS special agent, shot, killed at Phoenix-area gun range during training exerciseAugust 14, 2023 | thestreet.comHow to Avoid the IRS $3,000 Capital Loss Deduction RuleSee More Headlines Receive IRSB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Iris BioTechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2016Today4/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:IRSB Previous SymbolNASDAQ:IRSB CUSIPN/A CIK1396238 Webwww.irisbiotech.com Phone+1-408-8672885FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Simon S. M. Chin MBA (Age 60)Founder, Chairman, Chief Exec. Officer, Pres, Chief Financial Officer and Sec. Mr. James LeBlanc MBA (Age 72)VP of Operations Dr. Paul Yaswen Ph.D. (Age 61)Chief Scientific Officer Ms. Grace Osborne MBA (Age 52)VP of Bus. Devel. & HR and Director Dr. Ronald Mark Gemberling M.D. (Age 72)Chief Medical Officer Key CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors IRSB Stock Analysis - Frequently Asked Questions How have IRSB shares performed in 2024? Iris BioTechnologies' stock was trading at $0.04 on January 1st, 2024. Since then, IRSB shares have increased by 0.0% and is now trading at $0.04. View the best growth stocks for 2024 here. How were Iris BioTechnologies' earnings last quarter? Iris BioTechnologies Inc (OTCMKTS:IRSB) released its earnings results on Tuesday, November, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter. How do I buy shares of Iris BioTechnologies? Shares of IRSB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IRSB) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsIs Tesla going out of business?DTIThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iris BioTechnologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
